Skip to main content
OpenTrials

Clinical trial condition

Iron Overload

Explore clinical trials studying Iron Overload. Study availability and eligibility vary by location and protocol.

110 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Iron Overload trial results

Completed

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

NCT00061750

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's Hospital Oakland Oakland, California, United States
  • Stanford Hospital Stanford, California, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View Trial Details
Completed

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

NCT01039636

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations
  • Children's Hospital of Oakland Oakland, California, United States
  • Children's Hospital of Boston Boston, Massachusetts, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Royal Adelaide Hospital Adelaide, Australia
View Trial Details
Completed

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

NCT00349453

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations
  • Cantonal Hospital, Children's Clinic Aarau, Canton of Aargau, Switzerland
  • Cantonal Hospital Aarau, Canton of Aargau, Switzerland
  • Private children's practice Bern, Canton of Bern, Switzerland
  • Children's Hospital of Eastern Switzerland Sankt Gallen, Canton of St. Gallen, Switzerland
View all 13 locations
View Trial Details
Completed

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

NCT00171301

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations
  • Novartis Investigative Site Cairo, Egypt
  • Novartis Investigative Site Beirut, Lebanon
  • Novartis Investigative Site Muscat, Oman
  • Novartis Investigative Site Riyadh, Saudi Arabia
View Trial Details
Completed

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

NCT00395629

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hemochromatosis, +7 more
Locations
  • UC Irvine/Long Beach Long Beach, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 18 locations
View Trial Details
Completed

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

NCT00171210

Conditions
Iron Metabolism Disorders, Iron Overload, Metabolic Diseases, +2 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Stanford Hospital, Division of Oncology Stanford, California, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 49 locations
View Trial Details

Related conditions